img

Global Cardiology Radiopharmaceuticals Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cardiology Radiopharmaceuticals Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Cardiology Radiopharmaceuticals market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cardiology Radiopharmaceuticals market research.
Key companies engaged in the Cardiology Radiopharmaceuticals industry include GE Healthcare, Cardinal Health, Curium Pharma, Lantheus Medical Imaging, Inc., Eczacıbaşı Monrol Nuclear Products, Novartis International AG, Siemens, China Isotope & Radiation and Yantai Dongcheng Pharmaceutical, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Cardiology Radiopharmaceuticals were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cardiology Radiopharmaceuticals market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cardiology Radiopharmaceuticals market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GE Healthcare
Cardinal Health
Curium Pharma
Lantheus Medical Imaging, Inc.
Eczacıbaşı Monrol Nuclear Products
Novartis International AG
Siemens
China Isotope & Radiation
Yantai Dongcheng Pharmaceutical
Jubilant Life Sciences
Bracco
Segment by Type
Technetium-99
Fluorine-18
Gallium-67
Others

Segment by Application


Therapeutic Use
Diagnostic Use
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cardiology Radiopharmaceuticals report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiology Radiopharmaceuticals Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Technetium-99
1.2.3 Fluorine-18
1.2.4 Gallium-67
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cardiology Radiopharmaceuticals Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Therapeutic Use
1.3.3 Diagnostic Use
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiology Radiopharmaceuticals Market Perspective (2018-2029)
2.2 Cardiology Radiopharmaceuticals Growth Trends by Region
2.2.1 Global Cardiology Radiopharmaceuticals Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cardiology Radiopharmaceuticals Historic Market Size by Region (2018-2024)
2.2.3 Cardiology Radiopharmaceuticals Forecasted Market Size by Region (2024-2029)
2.3 Cardiology Radiopharmaceuticals Market Dynamics
2.3.1 Cardiology Radiopharmaceuticals Industry Trends
2.3.2 Cardiology Radiopharmaceuticals Market Drivers
2.3.3 Cardiology Radiopharmaceuticals Market Challenges
2.3.4 Cardiology Radiopharmaceuticals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiology Radiopharmaceuticals Players by Revenue
3.1.1 Global Top Cardiology Radiopharmaceuticals Players by Revenue (2018-2024)
3.1.2 Global Cardiology Radiopharmaceuticals Revenue Market Share by Players (2018-2024)
3.2 Global Cardiology Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cardiology Radiopharmaceuticals Revenue
3.4 Global Cardiology Radiopharmaceuticals Market Concentration Ratio
3.4.1 Global Cardiology Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiology Radiopharmaceuticals Revenue in 2022
3.5 Cardiology Radiopharmaceuticals Key Players Head office and Area Served
3.6 Key Players Cardiology Radiopharmaceuticals Product Solution and Service
3.7 Date of Enter into Cardiology Radiopharmaceuticals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiology Radiopharmaceuticals Breakdown Data by Type
4.1 Global Cardiology Radiopharmaceuticals Historic Market Size by Type (2018-2024)
4.2 Global Cardiology Radiopharmaceuticals Forecasted Market Size by Type (2024-2029)
5 Cardiology Radiopharmaceuticals Breakdown Data by Application
5.1 Global Cardiology Radiopharmaceuticals Historic Market Size by Application (2018-2024)
5.2 Global Cardiology Radiopharmaceuticals Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cardiology Radiopharmaceuticals Market Size (2018-2029)
6.2 North America Cardiology Radiopharmaceuticals Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cardiology Radiopharmaceuticals Market Size by Country (2018-2024)
6.4 North America Cardiology Radiopharmaceuticals Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiology Radiopharmaceuticals Market Size (2018-2029)
7.2 Europe Cardiology Radiopharmaceuticals Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cardiology Radiopharmaceuticals Market Size by Country (2018-2024)
7.4 Europe Cardiology Radiopharmaceuticals Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cardiology Radiopharmaceuticals Market Size (2018-2029)
8.2 Asia-Pacific Cardiology Radiopharmaceuticals Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cardiology Radiopharmaceuticals Market Size by Region (2018-2024)
8.4 Asia-Pacific Cardiology Radiopharmaceuticals Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cardiology Radiopharmaceuticals Market Size (2018-2029)
9.2 Latin America Cardiology Radiopharmaceuticals Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cardiology Radiopharmaceuticals Market Size by Country (2018-2024)
9.4 Latin America Cardiology Radiopharmaceuticals Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiology Radiopharmaceuticals Market Size (2018-2029)
10.2 Middle East & Africa Cardiology Radiopharmaceuticals Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Country (2018-2024)
10.4 Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Cardiology Radiopharmaceuticals Introduction
11.1.4 GE Healthcare Revenue in Cardiology Radiopharmaceuticals Business (2018-2024)
11.1.5 GE Healthcare Recent Development
11.2 Cardinal Health
11.2.1 Cardinal Health Company Detail
11.2.2 Cardinal Health Business Overview
11.2.3 Cardinal Health Cardiology Radiopharmaceuticals Introduction
11.2.4 Cardinal Health Revenue in Cardiology Radiopharmaceuticals Business (2018-2024)
11.2.5 Cardinal Health Recent Development
11.3 Curium Pharma
11.3.1 Curium Pharma Company Detail
11.3.2 Curium Pharma Business Overview
11.3.3 Curium Pharma Cardiology Radiopharmaceuticals Introduction
11.3.4 Curium Pharma Revenue in Cardiology Radiopharmaceuticals Business (2018-2024)
11.3.5 Curium Pharma Recent Development
11.4 Lantheus Medical Imaging, Inc.
11.4.1 Lantheus Medical Imaging, Inc. Company Detail
11.4.2 Lantheus Medical Imaging, Inc. Business Overview
11.4.3 Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Introduction
11.4.4 Lantheus Medical Imaging, Inc. Revenue in Cardiology Radiopharmaceuticals Business (2018-2024)
11.4.5 Lantheus Medical Imaging, Inc. Recent Development
11.5 Eczacıbaşı Monrol Nuclear Products
11.5.1 Eczacıbaşı Monrol Nuclear Products Company Detail
11.5.2 Eczacıbaşı Monrol Nuclear Products Business Overview
11.5.3 Eczacıbaşı Monrol Nuclear Products Cardiology Radiopharmaceuticals Introduction
11.5.4 Eczacıbaşı Monrol Nuclear Products Revenue in Cardiology Radiopharmaceuticals Business (2018-2024)
11.5.5 Eczacıbaşı Monrol Nuclear Products Recent Development
11.6 Novartis International AG
11.6.1 Novartis International AG Company Detail
11.6.2 Novartis International AG Business Overview
11.6.3 Novartis International AG Cardiology Radiopharmaceuticals Introduction
11.6.4 Novartis International AG Revenue in Cardiology Radiopharmaceuticals Business (2018-2024)
11.6.5 Novartis International AG Recent Development
11.7 Siemens
11.7.1 Siemens Company Detail
11.7.2 Siemens Business Overview
11.7.3 Siemens Cardiology Radiopharmaceuticals Introduction
11.7.4 Siemens Revenue in Cardiology Radiopharmaceuticals Business (2018-2024)
11.7.5 Siemens Recent Development
11.8 China Isotope & Radiation
11.8.1 China Isotope & Radiation Company Detail
11.8.2 China Isotope & Radiation Business Overview
11.8.3 China Isotope & Radiation Cardiology Radiopharmaceuticals Introduction
11.8.4 China Isotope & Radiation Revenue in Cardiology Radiopharmaceuticals Business (2018-2024)
11.8.5 China Isotope & Radiation Recent Development
11.9 Yantai Dongcheng Pharmaceutical
11.9.1 Yantai Dongcheng Pharmaceutical Company Detail
11.9.2 Yantai Dongcheng Pharmaceutical Business Overview
11.9.3 Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Introduction
11.9.4 Yantai Dongcheng Pharmaceutical Revenue in Cardiology Radiopharmaceuticals Business (2018-2024)
11.9.5 Yantai Dongcheng Pharmaceutical Recent Development
11.10 Jubilant Life Sciences
11.10.1 Jubilant Life Sciences Company Detail
11.10.2 Jubilant Life Sciences Business Overview
11.10.3 Jubilant Life Sciences Cardiology Radiopharmaceuticals Introduction
11.10.4 Jubilant Life Sciences Revenue in Cardiology Radiopharmaceuticals Business (2018-2024)
11.10.5 Jubilant Life Sciences Recent Development
11.11 Bracco
11.11.1 Bracco Company Detail
11.11.2 Bracco Business Overview
11.11.3 Bracco Cardiology Radiopharmaceuticals Introduction
11.11.4 Bracco Revenue in Cardiology Radiopharmaceuticals Business (2018-2024)
11.11.5 Bracco Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cardiology Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Technetium-99
Table 3. Key Players of Fluorine-18
Table 4. Key Players of Gallium-67
Table 5. Key Players of Others
Table 6. Global Cardiology Radiopharmaceuticals Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Cardiology Radiopharmaceuticals Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Cardiology Radiopharmaceuticals Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Cardiology Radiopharmaceuticals Market Share by Region (2018-2024)
Table 10. Global Cardiology Radiopharmaceuticals Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Cardiology Radiopharmaceuticals Market Share by Region (2024-2029)
Table 12. Cardiology Radiopharmaceuticals Market Trends
Table 13. Cardiology Radiopharmaceuticals Market Drivers
Table 14. Cardiology Radiopharmaceuticals Market Challenges
Table 15. Cardiology Radiopharmaceuticals Market Restraints
Table 16. Global Cardiology Radiopharmaceuticals Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Cardiology Radiopharmaceuticals Market Share by Players (2018-2024)
Table 18. Global Top Cardiology Radiopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiology Radiopharmaceuticals as of 2022)
Table 19. Ranking of Global Top Cardiology Radiopharmaceuticals Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Cardiology Radiopharmaceuticals Revenue (CR5 and HHI) & (2018-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cardiology Radiopharmaceuticals Product Solution and Service
Table 23. Date of Enter into Cardiology Radiopharmaceuticals Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cardiology Radiopharmaceuticals Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Cardiology Radiopharmaceuticals Revenue Market Share by Type (2018-2024)
Table 27. Global Cardiology Radiopharmaceuticals Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Cardiology Radiopharmaceuticals Revenue Market Share by Type (2024-2029)
Table 29. Global Cardiology Radiopharmaceuticals Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Cardiology Radiopharmaceuticals Revenue Market Share by Application (2018-2024)
Table 31. Global Cardiology Radiopharmaceuticals Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Cardiology Radiopharmaceuticals Revenue Market Share by Application (2024-2029)
Table 33. North America Cardiology Radiopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Cardiology Radiopharmaceuticals Market Size by Country (2018-2024) & (US$ Million)
Table 35. North America Cardiology Radiopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Cardiology Radiopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Cardiology Radiopharmaceuticals Market Size by Country (2018-2024) & (US$ Million)
Table 38. Europe Cardiology Radiopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Cardiology Radiopharmaceuticals Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Cardiology Radiopharmaceuticals Market Size by Region (2018-2024) & (US$ Million)
Table 41. Asia-Pacific Cardiology Radiopharmaceuticals Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Cardiology Radiopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Cardiology Radiopharmaceuticals Market Size by Country (2018-2024) & (US$ Million)
Table 44. Latin America Cardiology Radiopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Cardiology Radiopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Country (2018-2024) & (US$ Million)
Table 47. Middle East & Africa Cardiology Radiopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
Table 48. GE Healthcare Company Detail
Table 49. GE Healthcare Business Overview
Table 50. GE Healthcare Cardiology Radiopharmaceuticals Product
Table 51. GE Healthcare Revenue in Cardiology Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 52. GE Healthcare Recent Development
Table 53. Cardinal Health Company Detail
Table 54. Cardinal Health Business Overview
Table 55. Cardinal Health Cardiology Radiopharmaceuticals Product
Table 56. Cardinal Health Revenue in Cardiology Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 57. Cardinal Health Recent Development
Table 58. Curium Pharma Company Detail
Table 59. Curium Pharma Business Overview
Table 60. Curium Pharma Cardiology Radiopharmaceuticals Product
Table 61. Curium Pharma Revenue in Cardiology Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 62. Curium Pharma Recent Development
Table 63. Lantheus Medical Imaging, Inc. Company Detail
Table 64. Lantheus Medical Imaging, Inc. Business Overview
Table 65. Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Product
Table 66. Lantheus Medical Imaging, Inc. Revenue in Cardiology Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 67. Lantheus Medical Imaging, Inc. Recent Development
Table 68. Eczacıbaşı Monrol Nuclear Products Company Detail
Table 69. Eczacıbaşı Monrol Nuclear Products Business Overview
Table 70. Eczacıbaşı Monrol Nuclear Products Cardiology Radiopharmaceuticals Product
Table 71. Eczacıbaşı Monrol Nuclear Products Revenue in Cardiology Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 72. Eczacıbaşı Monrol Nuclear Products Recent Development
Table 73. Novartis International AG Company Detail
Table 74. Novartis International AG Business Overview
Table 75. Novartis International AG Cardiology Radiopharmaceuticals Product
Table 76. Novartis International AG Revenue in Cardiology Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 77. Novartis International AG Recent Development
Table 78. Siemens Company Detail
Table 79. Siemens Business Overview
Table 80. Siemens Cardiology Radiopharmaceuticals Product
Table 81. Siemens Revenue in Cardiology Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 82. Siemens Recent Development
Table 83. China Isotope & Radiation Company Detail
Table 84. China Isotope & Radiation Business Overview
Table 85. China Isotope & Radiation Cardiology Radiopharmaceuticals Product
Table 86. China Isotope & Radiation Revenue in Cardiology Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 87. China Isotope & Radiation Recent Development
Table 88. Yantai Dongcheng Pharmaceutical Company Detail
Table 89. Yantai Dongcheng Pharmaceutical Business Overview
Table 90. Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Product
Table 91. Yantai Dongcheng Pharmaceutical Revenue in Cardiology Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 92. Yantai Dongcheng Pharmaceutical Recent Development
Table 93. Jubilant Life Sciences Company Detail
Table 94. Jubilant Life Sciences Business Overview
Table 95. Jubilant Life Sciences Cardiology Radiopharmaceuticals Product
Table 96. Jubilant Life Sciences Revenue in Cardiology Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 97. Jubilant Life Sciences Recent Development
Table 98. Bracco Company Detail
Table 99. Bracco Business Overview
Table 100. Bracco Cardiology Radiopharmaceuticals Product
Table 101. Bracco Revenue in Cardiology Radiopharmaceuticals Business (2018-2024) & (US$ Million)
Table 102. Bracco Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cardiology Radiopharmaceuticals Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Cardiology Radiopharmaceuticals Market Share by Type: 2022 VS 2029
Figure 3. Technetium-99 Features
Figure 4. Fluorine-18 Features
Figure 5. Gallium-67 Features
Figure 6. Others Features
Figure 7. Global Cardiology Radiopharmaceuticals Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 8. Global Cardiology Radiopharmaceuticals Market Share by Application: 2022 VS 2029
Figure 9. Therapeutic Use Case Studies
Figure 10. Diagnostic Use Case Studies
Figure 11. Cardiology Radiopharmaceuticals Report Years Considered
Figure 12. Global Cardiology Radiopharmaceuticals Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Cardiology Radiopharmaceuticals Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Cardiology Radiopharmaceuticals Market Share by Region: 2022 VS 2029
Figure 15. Global Cardiology Radiopharmaceuticals Market Share by Players in 2022
Figure 16. Global Top Cardiology Radiopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiology Radiopharmaceuticals as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cardiology Radiopharmaceuticals Revenue in 2022
Figure 18. North America Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Cardiology Radiopharmaceuticals Market Share by Country (2018-2029)
Figure 20. United States Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Cardiology Radiopharmaceuticals Market Share by Country (2018-2029)
Figure 24. Germany Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Cardiology Radiopharmaceuticals Market Share by Region (2018-2029)
Figure 32. China Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Cardiology Radiopharmaceuticals Market Share by Country (2018-2029)
Figure 40. Mexico Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Cardiology Radiopharmaceuticals Market Share by Country (2018-2029)
Figure 44. Turkey Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Cardiology Radiopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. GE Healthcare Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2018-2024)
Figure 47. Cardinal Health Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2018-2024)
Figure 48. Curium Pharma Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2018-2024)
Figure 49. Lantheus Medical Imaging, Inc. Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2018-2024)
Figure 50. Eczacıbaşı Monrol Nuclear Products Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2018-2024)
Figure 51. Novartis International AG Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2018-2024)
Figure 52. Siemens Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2018-2024)
Figure 53. China Isotope & Radiation Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2018-2024)
Figure 54. Yantai Dongcheng Pharmaceutical Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2018-2024)
Figure 55. Jubilant Life Sciences Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2018-2024)
Figure 56. Bracco Revenue Growth Rate in Cardiology Radiopharmaceuticals Business (2018-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed